Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

Fractional Laser vs. Ultrasound for Periorbital Wrinkles

Not Applicable

Active, not recruiting

Conditions: Wrinkles

Interventions: Procedure: Laser treatment

First Posted Date: 2012-02-09

Last Posted Date: 2024-03-18

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT01529983

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

Pulsed Dye Laser (PDL) vs. Microsecond 1064-nm Nd:YAG Laser for Treatment of Diffuse Facial Redness

Not Applicable

Completed

Conditions: Rosacea

Interventions: Procedure: Pulse Dye Laser/YAG laser

First Posted Date: 2012-02-09

Last Posted Date: 2021-12-02

Lead Sponsor: Northwestern University

Target Recruit Count: 16

Registration Number: NCT01529996

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Department of Dermatology, Chicago, Illinois, United States

PharmacoMRI of Parkinson Disease

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Carbidopa-Levodopa

First Posted Date: 2012-02-08

Last Posted Date: 2018-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 18

Registration Number: NCT01528592

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Brain Imaging of Lidoderm for Chronic Back Pain

Phase 4

Completed

Conditions: Low Back Pain

Interventions: Drug: lidocaine
Drug: placebo

First Posted Date: 2012-01-24

Last Posted Date: 2013-07-30

Lead Sponsor: Northwestern University

Target Recruit Count: 38

Registration Number: NCT01515540

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Intracutaneous Sterile Water Injections

Not Applicable

Terminated

Conditions: Labor Pain

Interventions: Drug: Intracutaneous injections

First Posted Date: 2012-01-20

Last Posted Date: 2015-03-02

Lead Sponsor: Northwestern University

Target Recruit Count: 8

Registration Number: NCT01513447

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

Evaluation of the Effectiveness of Daily Pulse Lavage Therapy in Chronic Wounds

Not Applicable

Completed

Conditions: Chronic Wounds

Interventions: Procedure: Pulse lavage treatment
Other: Dressing changes

First Posted Date: 2011-12-28

Last Posted Date: 2014-04-14

Lead Sponsor: Northwestern University

Target Recruit Count: 8

Registration Number: NCT01500746

Locations: 🇺🇸
Northwestern Memorial Hospital, Chicago, Illinois, United States

A Randomized Study to Abate Truancy and Violence in Grades 3-9 in Chicago Public Schools

Not Applicable

Completed

Conditions: Dropout
Attendance and Truancy
Student Engagement

Interventions: Behavioral: Check & Connect

First Posted Date: 2011-12-07

Last Posted Date: 2020-09-09

Lead Sponsor: Northwestern University

Target Recruit Count: 5300

Registration Number: NCT01487434

Locations: 🇺🇸
Chicago Public Schools, Chicago, Illinois, United States

Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas

Phase 2

Terminated

Conditions: Adult Anaplastic Ependymoma
Adult Giant Cell Glioblastoma
Adult Anaplastic Oligodendroglioma
Adult Anaplastic Astrocytoma
Adult Glioblastoma

Interventions: Drug: Temozolomide
Radiation: hypofractionated radiation therapy
Biological: bevacizumab
Other: questionnaire administration

First Posted Date: 2011-11-23

Last Posted Date: 2020-03-12

Lead Sponsor: Northwestern University

Target Recruit Count: 54

Registration Number: NCT01478321

Locations: 🇺🇸
Northwestern Lake Forest Hospital, Lake Forest, Illinois, United States
🇺🇸
Edward Cancer Center, Naperville, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

and more 2 locations

Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma

Phase 2

Conditions: Adult Lymphocyte Depletion Hodgkin Lymphoma
Adult Lymphocyte Predominant Hodgkin Lymphoma
Adult Mixed Cellularity Hodgkin Lymphoma
Adult Nodular Sclerosis Hodgkin Lymphoma
Stage II Adult Hodgkin Lymphoma
Stage III Adult Hodgkin Lymphoma
Stage IV Adult Hodgkin Lymphoma

Interventions: Drug: brentuximab vedotin
Drug: doxorubicin hydrochloride
Drug: vinblastine
Drug: dacarbazine
Procedure: quality-of-life assessment
Genetic: DNA analysis
Genetic: RNA analysis
Radiation: fludeoxyglucose F 18
Procedure: positron emission tomography
Other: laboratory biomarker analysis
Other: immunohistochemistry staining method
Genetic: polymorphism analysis

First Posted Date: 2011-11-22

Last Posted Date: 2020-02-17

Lead Sponsor: Northwestern University

Target Recruit Count: 48

Registration Number: NCT01476410

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
Stanford University Medical Center, Stanford, California, United States
🇺🇸
Memorial Sloan- Kettering Cancer Center, New York, New York, United States

and more 4 locations

Ipilimumab and Gemcitabine Hydrochloride in Treating Patients With Stage III-IV or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery

Phase 1

Completed

Conditions: Duct Cell Adenocarcinoma of the Pancreas
Recurrent Pancreatic Cancer
Stage III Pancreatic Cancer
Stage IV Pancreatic Cancer

Interventions: Biological: ipilimumab
Drug: gemcitabine hydrochloride
Other: laboratory biomarker analysis

First Posted Date: 2011-11-17

Last Posted Date: 2020-03-06

Lead Sponsor: Northwestern University

Target Recruit Count: 21

Registration Number: NCT01473940

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy